SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041793
Filing Date
2019-11-07
Accepted
2019-11-07 16:27:13
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20190930.htm   iXBRL 10-Q 2757816
2 EX-10.1 pbyi-ex101_131.htm EX-10.1 30062
3 EX-31.1 pbyi-ex311_7.htm EX-31.1 9314
4 EX-31.2 pbyi-ex312_9.htm EX-31.2 9313
5 EX-32.1 pbyi-ex321_6.htm EX-32.1 6279
6 EX-32.2 pbyi-ex322_10.htm EX-32.2 6299
  Complete submission text file 0001564590-19-041793.txt   9936055

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20190930.xsd EX-101.SCH 60251
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20190930_cal.xml EX-101.CAL 65810
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20190930_def.xml EX-101.DEF 173759
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20190930_lab.xml EX-101.LAB 502481
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20190930_pre.xml EX-101.PRE 358822
49 EXTRACTED XBRL INSTANCE DOCUMENT pbyi-10q_20190930_htm.xml XML 2064781
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 191200760
SIC: 2834 Pharmaceutical Preparations